[Federal Register Volume 77, Number 63 (Monday, April 2, 2012)]
[Notices]
[Page 19718]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-7750]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration, 
Norac Inc.

    By Notice dated December 20, 2011, and published in the Federal 
Register on December 29, 2011, 76 FR 81979, Norac Inc., 405 S. Motor 
Avenue, Azusa, California 91702-3232, made application by renewal to 
the Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the following basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)...........  I
Tetrahydrocannabinols (7370)...............  I
Methamphetamine (1105).....................  II
Pentobarbital (2270).......................  II
Nabilone (7379)............................  II
------------------------------------------------------------------------

    With regard to Gamma Hydroxybutyric Acid (2010), 
Tetrahydrocannabinols (7370), and Methamphetamine (1105) only, the 
company manufactures these controlled substances in bulk solely for 
domestic distribution within the United States to customers engaged in 
dosage-form manufacturing.
    With regard to Nabilone (7379) only, the company presently 
manufactures a small amount of this controlled substance in bulk solely 
to conduct manufacturing internal process development. It is the 
company's intention once the manufacturing process is refined to the 
point that its Nabilone bulk product is available for commercial use, 
the company will export the controlled substance in bulk solely to 
customers engaged in dosage-form manufacturing outside the United 
States. The company is aware of the requirement to obtain a DEA 
registration as an exporter to conduct this activity.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Norac, Inc. to manufacture the listed basic classes of controlled 
substances is consistent with the public interest at this time. DEA has 
investigated Norac, Inc. to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 USC Sec.  823(a), and in accordance with 21 CFR 1301.33, the 
above named company is granted registration as a bulk manufacturer of 
the basic classes of controlled substances listed.

    Dated: March 23, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-7750 Filed 3-30-12; 8:45 am]
BILLING CODE 4410-09-P